Inhibikase Therapeutics, Inc. (IKT)
1.67
+0.02
(+1.21%)
USD |
NASDAQ |
Jan 16, 16:00
1.67
0.00 (0.00%)
After-Hours: 20:00
Inhibikase Therapeutics Price: 1.67 for Jan. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CEL-SCI Corp. | 5.15 |
| AIM ImmunoTech, Inc. | 1.34 |
| IGC Pharma, Inc. | 0.2963 |
| NovaBay Pharmaceuticals, Inc. | 14.77 |
| Protalix Biotherapeutics, Inc. | 2.04 |
Price Related Metrics
| Price to Book Value | 2.778 |
| Earnings Yield | -34.16% |
| Market Cap | 202.52M |